Healthcare Sector

Members of Parliament invested in the Healthcare Sector

160 investments

71 companies

Investors

Filed	Name	Company	Pur. £	Cur. £	P/L %	MPV*
Feb '17	Lord Arbuthnot of Edrom	Neuro-bio / NMS:NBIX	£43.24	£140.71	225.42%	£227,791.40
Apr '16	Baroness Greenfield	Neuro-bio / NMS:NBIX	£46.13	£140.71	205.03%	£213,520.49
Apr '24	Lord Balfe	Astrazeneca / LSE:AZN.L	£12,024.00	£12,032.00	0.07%	£70,046.57
Dec '16	Lord Burns	Astrazeneca / LSE:AZN.L	£4,116.00	£12,032.00	192.32%	£204,625.85
May '20	Lord Deighton	Astrazeneca / LSE:AZN.L	£8,361.00	£11,236.00	34.39%	£94,070.09**
Mar '14	Viscount Eccles	Astrazeneca / LSE:AZN.L	£3,876.50	£15,316.00	295.10%	£276,569.07**
Feb '21	Lord Etherton	Astrazeneca / LSE:AZN.L	£7,422.00	£12,032.00	62.11%	£113,478.85
May '23	Lord Fink	Astrazeneca / LSE:AZN.L	£11,774.00	£12,032.00	2.19%	£71,533.89
Sep '16	Lord Gadhia	Astrazeneca / LSE:AZN.L	£5,099.00	£10,024.00	96.59%	£137,611.30**
Apr '12	Lord Glendonbrook	Astrazeneca / LSE:AZN.L	£2,666.50	£12,032.00	351.23%	£315,859.74
May '24	Lord Goldsmith	Astrazeneca / LSE:AZN.L	£12,156.00	£12,032.00	-1.02%	£69,285.95
May '18	Lord Grabiner	Astrazeneca / LSE:AZN.L	£5,417.00	£12,032.00	122.12%	£155,480.89
May '23	Lord Leitch	Astrazeneca / LSE:AZN.L	£11,820.00	£12,340.00	4.40%	£73,079.53**
May '23	Lord Londesborough	Astrazeneca / LSE:AZN.L	£11,924.00	£12,032.00	0.91%	£70,634.02
Nov '23	Lord Mance	Astrazeneca / LSE:AZN.L	£10,230.00	£12,032.00	17.61%	£82,330.40
Jun '21	Lord Morse	Astrazeneca / LSE:AZN.L	£8,005.00	£12,032.00	50.31%	£105,214.24
Apr '10	Baroness Noakes	Astrazeneca / LSE:AZN.L	£2,938.00	£12,032.00	309.53%	£286,671.20
Dec '23	Lord Browne of Madingley	Allurion / NYQ:ALUR	£3.31	£0.78	-76.53%	£16,432.02
Dec '16	Lord Burns	Glaxosmithkline / NYQ:GSK	£37.39	£47.18	26.18%	£88,328.43
Mar '14	Baroness Eccles of Moulton	Glaxosmithkline / NYQ:GSK	£53.43	£56.69	6.10%	£74,271.01**
Apr '21	Lord Farmer	Glaxosmithkline / NYQ:GSK	£36.65	£40.88	11.54%	£78,079.12**
Jan '20	Lord Gadhia	Glaxosmithkline / NYQ:GSK	£46.50	£40.95	-11.94%	£61,645.16**
May '11	Lord Glendonbrook	Glaxosmithkline / NYQ:GSK	£42.78	£47.18	10.29%	£77,199.63
Apr '10	Lord Levene of Portsoken	Glaxosmithkline / NYQ:GSK	£39.38	£47.18	19.81%	£83,864.90
Mar '17	Lord Lloyd-Webber	Glaxosmithkline / NYQ:GSK	£42.31	£47.18	11.51%	£78,057.20
Apr '10	Baroness Noakes	Glaxosmithkline / NYQ:GSK	£39.49	£47.18	19.47%	£83,631.30
Jan '13	Lord Sassoon	Glaxosmithkline / NYQ:GSK	£44.75	£47.18	5.43%	£73,801.12
Oct '20	Lord Taverne	Glaxosmithkline / NYQ:GSK	£37.57	£40.95	9.00%	£76,297.58**
May '24	Lord Balfe	Glaxosmithkline / NYQ:GSK	£44.02	£47.18	7.18%	£75,024.99
May '25	Lord Hayward	Glaxosmithkline / NYQ:GSK	£37.37	£47.18	26.25%	£88,375.71
Aug '14	Lord Carter of Coles	Johnson & Johnson / NYQ:JNJ	£100.16	£161.55	61.29%	£112,904.35**
Apr '22	Lord Cromwell	Johnson & Johnson / NYQ:JNJ	£179.90	£154.37	-14.19%	£60,066.15**
May '23	Lord Fink	Johnson & Johnson / NYQ:JNJ	£165.03	£258.66	56.74%	£109,714.60
Jul '16	Lord Lloyd-Webber	Johnson & Johnson / NYQ:JNJ	£122.64	£258.66	110.91%	£147,636.99
Jan '13	Lord Sassoon	Johnson & Johnson / NYQ:JNJ	£72.69	£258.66	255.84%	£249,087.90
Aug '17	Lord Sterling of Plaistow	Johnson & Johnson / NYQ:JNJ	£133.45	£157.98	18.38%	£82,866.99**
Feb '11	Lord Wasserman	Johnson & Johnson / NYQ:JNJ	£60.93	£258.66	324.52%	£297,163.96
Mar '25	Lord Fink	Johnson & Johnson / NYQ:JNJ	£161.72	£258.66	59.94%	£111,960.18
Aug '18	Lord Carter of Coles	Danaher / NYQ:DHR	£90.94	£223.01	145.23%	£171,659.87**
Apr '22	Lord Cromwell	Danaher / NYQ:DHR	£245.55	£201.40	-17.98%	£57,414.25**
Jul '16	Lord Glendonbrook	Danaher / NYQ:DHR	£72.15	£211.76	193.48%	£205,437.63
Apr '22	Lord Grabiner	Danaher / NYQ:DHR	£248.88	£198.61	-20.20%	£55,860.39**
Aug '17	Lord Sterling of Plaistow	Danaher / NYQ:DHR	£71.88	£212.78	196.02%	£207,216.44**
Jul '18	Lord Carter of Coles	Essilor International / VIE:EI.VI	£126.10	£316.70	151.15%	£175,804.93**
Aug '18	Lord Carter of Coles	Unitedhealth Group / NYQ:UNH	£253.22	£365.20	44.22%	£100,955.69
Jan '23	Lord Goldsmith	Unitedhealth Group / NYQ:UNH	£490.06	£379.86	-22.49%	£54,259.07**
Nov '23	Lord Mance	Unitedhealth Group / NYQ:UNH	£537.83	£409.25	-23.91%	£53,264.97**
Jan '18	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£221.16	£380.64	72.11%	£120,477.48**
Mar '25	Lord Fink	Unitedhealth Group / NYQ:UNH	£518.20	£365.20	-29.53%	£49,332.30
Apr '25	Lord Grabiner	Unitedhealth Group / NYQ:UNH	£594.40	£400.94	-32.55%	£47,217.02**
Oct '25	Lord Sterling of Plaistow	Unitedhealth Group / NYQ:UNH	£361.15	£356.26	-1.35%	£69,052.20**
Feb '19	Lord Carter of Coles	Mettler Toledo / NYQ:MTD	£672.49	£1,481.17	120.25%	£154,176.13
May '19	Lord Sterling of Plaistow	Mettler Toledo / NYQ:MTD	£701.77	£1,481.07	111.05%	£147,733.44**
Sep '20	Lord Carter of Coles	Thermo Fisher Scientific / NYQ:TMO	£418.14	£652.51	56.05%	£109,235.42
Apr '22	Lord Grabiner	Thermo Fisher Scientific / NYQ:TMO	£570.94	£438.15	-23.26%	£53,719.30**
May '18	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£215.97	£423.55	96.12%	£137,280.64**
Nov '23	Lord Mance	Thermo Fisher Scientific / NYQ:TMO	£459.24	£652.51	42.08%	£99,459.33
Aug '20	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£416.17	£403.13	-3.13%	£67,806.66**
Jan '25	Lord Sassoon	Thermo Fisher Scientific / NYQ:TMO	£583.64	£652.51	11.80%	£78,260.06
Aug '25	Lord Green of Hurstpierpoint	Thermo Fisher Scientific / NYQ:TMO	£463.04	£652.51	40.92%	£98,643.10
Aug '25	Lord Sterling of Plaistow	Thermo Fisher Scientific / NYQ:TMO	£477.41	£475.66	-0.37%	£69,743.41**
Sep '21	Lord Darzi of Denham	Oxford Nanopore / LSE:ONT.L	£612.60	£214.00	-65.07%	£24,453.15
Apr '22	Lord Spencer of Alresford	Oxford Nanopore / LSE:ONT.L	£320.00	£214.00	-33.13%	£46,812.50
Apr '21	Baroness Deech	Novo Nordisk As / NYQ:NVO	£36.35	£37.40	2.89%	£72,022.02
Apr '24	Lord Grabiner	Novo Nordisk As / NYQ:NVO	£127.46	£64.73	-49.22%	£35,549.19**
Nov '23	Lord Mance	Novo Nordisk As / NYQ:NVO	£101.69	£37.40	-63.22%	£25,744.91
May '22	Lord Reay	Novo Nordisk As / NYQ:NVO	£56.40	£140.80	149.67%	£174,767.27**
Nov '21	Lord Sherbourne of Didsbury	Novo Nordisk As / NYQ:NVO	£56.71	£70.73	24.73%	£87,313.29**
Apr '24	Lord Willoughby de Broke	Novo Nordisk As / NYQ:NVO	£122.75	£37.40	-69.53%	£21,327.90
May '24	Lord Londesborough	Novo Nordisk As / NYQ:NVO	£134.66	£37.40	-72.23%	£19,441.56
Apr '21	Baroness Deech	Zoetis / NYQ:ZTS	£168.10	£73.79	-56.10%	£30,727.54**
Mar '25	Lord Fink	Zoetis / NYQ:ZTS	£162.82	£69.10	-57.56%	£29,707.65
Apr '21	Baroness Deech	Novartis / NYQ:NVS	£88.38	£141.05	59.59%	£111,716.46
Apr '17	Lord Donoughue	Novartis / NYQ:NVS	£66.05	£141.05	113.56%	£149,488.89
May '11	Lord Glendonbrook	Novartis / NYQ:NVS	£54.04	£141.05	161.00%	£182,703.14
Apr '23	Lord Grabiner	Novartis / NYQ:NVS	£95.80	£107.52	12.23%	£78,563.67**
Oct '19	Lord Farmer	Centene / NYQ:CNC	£44.09	£72.71	64.91%	£115,438.87**
May '23	Lord Fink	Healthcare Group / LSE:SPI.L	£227.50	£247.50	8.79%	£76,153.85
Jan '24	Lord Fink	Roche / EBS:ROG.SW	£251.85	£321.70	27.73%	£89,414.34
Apr '21	Lord Grabiner	Roche / EBS:ROG.SW	£309.65	£321.70	3.89%	£72,724.05
Apr '17	Lord Leigh of Hurley	Roche / EBS:ROG.SW	£255.80	£321.70	25.76%	£88,033.62
Aug '20	Lord Reay	Roche / EBS:ROG.SW	£315.05	£249.80	-20.71%	£55,502.30**
Feb '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£285.70	£272.40	-4.66%	£66,741.33**
Mar '25	Lord Fink	Roche / EBS:ROG.SW	£303.00	£321.70	6.17%	£74,320.13
Nov '25	Lord Green of Hurstpierpoint	Roche / EBS:ROG.SW	£309.00	£321.70	4.11%	£72,877.03
May '11	Lord Glendonbrook	Abbott Laboratories / NYQ:ABT	£25.27	£96.69	282.68%	£267,878.90
May '23	Lord Londesborough	Abbott Laboratories / NYQ:ABT	£108.82	£96.69	-11.15%	£62,197.21
Jan '13	Lord Sassoon	Abbott Laboratories / NYQ:ABT	£32.90	£96.69	193.89%	£205,723.40
May '11	Lord Glendonbrook	Mesoblast / NMS:MESO	£101.20	£14.32	-85.85%	£9,905.14
May '11	Lord Glendonbrook	Pfizer / NYQ:PFE	£19.54	£28.12	43.88%	£100,713.28
Feb '16	Lord Lloyd-Webber	Pfizer / NYQ:PFE	£29.02	£28.12	-3.11%	£67,822.61
Aug '26	Lord Sassoon	Pfizer / NYQ:PFE	£27.97	£28.12	0.54%	£70,375.41
May '11	Lord Glendonbrook	Smith & Nephew / NYQ:SNN	£22.61	£26.58	17.58%	£82,309.07
Apr '10	Baroness Noakes	Smith & Nephew / NYQ:SNN	£20.98	£26.58	26.69%	£88,682.80
Aug '26	Baroness Deech	Smith & Nephew / NYQ:SNN	£29.84	£26.58	-10.92%	£62,352.55
Jan '13	Lord Glendonbrook	Waters / NYQ:WAT	£87.09	£425.53	388.61%	£342,026.65
Oct '13	Lord Glendonbrook	Stryker / NYQ:SYK	£69.42	£272.96	293.20%	£275,240.56
Nov '23	Lord Mance	Stryker / NYQ:SYK	£275.00	£272.96	-0.74%	£69,480.73
Mar '14	Lord Glendonbrook	Bb Biotech / EBS:BION.SW	£33.36	£27.20	-18.47%	£57,074.34**
Jun '16	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£47.80	£50.90	6.49%	£74,539.75
Mar '17	Lord Lloyd-Webber	Bb Biotech / EBS:BION.SW	£54.95	£50.90	-7.37%	£64,840.77
Oct '20	Lord Glendonbrook	Bds / NGM:BDSX	£12.81	£27.33	113.35%	£149,344.26
May '15	Lord Glendonbrook	Medtronic / NYQ:MDT	£78.41	£86.77	10.66%	£77,463.33**
Dec '25	Lord Sassoon	Medtronic / NYQ:MDT	£100.77	£86.44	-14.22%	£60,045.65
Jan '18	Lord Glendonbrook	Cvs Health / NYQ:CVS	£79.44	£85.20	7.25%	£75,075.52
Feb '13	Lord Nash	Cvs Health / NYQ:CVS	£52.66	£77.90	47.93%	£103,551.08**
Jul '18	Lord Glendonbrook	Bayer / GER:BAYN.DE	£95.26	£45.40	-52.34%	£33,361.33
Aug '26	Baroness Deech	Bayer / GER:BAYN.DE	£48.00	£45.40	-5.42%	£66,208.34
Jun '19	Lord Glendonbrook	Alcon / NYQ:ALC	£59.11	£80.92	36.90%	£95,828.11**
Dec '19	Lord Glendonbrook	Align Technology / NMS:ALGN	£273.75	£145.35	-46.90%	£37,167.12
May '24	Lord Goldsmith	Abbvie / NYQ:ABBV	£160.81	£259.93	61.64%	£113,146.57
Apr '21	Lord Grabiner	Boston Scientific / NYQ:BSX	£39.32	£93.67	138.22%	£166,757.37**
Apr '22	Lord Grabiner	Intuitive Surgical / NMS:ISRG	£277.85	£401.24	44.41%	£101,086.19
Jan '22	Lord Green of Hurstpierpoint	Intuitive Surgical / NMS:ISRG	£284.18	£529.42	86.30%	£130,408.19**
Nov '21	Lord Sherbourne of Didsbury	Intuitive Surgical / NMS:ISRG	£350.79	£401.24	14.38%	£80,067.27
Oct '25	Lord Carter of Coles	Intuitive Surgical / NMS:ISRG	£551.30	£401.24	-27.22%	£50,946.49
Oct '15	Lord Hayward	Sage / NGM:SAGE	£46.11	£8.68	-81.18%	£13,177.19
Dec '22	Lord Hintze	Atai Life Sciences / NGM:ATAI	£3.48	£3.87	11.21%	£77,844.83**
Dec '22	Lord Hintze	Affimed / NGM:AFMD	£21.20	£0.18	-99.14%	£599.29**
Mar '11	Lord Hollick	HCA / NYQ:HCA	£31.02	£423.39	1,264.89%	£955,425.56
Nov '17	Lord Howard of Rising	Ekf Diagnostics / LSE:EKF.L	£25.01	£24.70	-1.24%	£69,131.79
Apr '22	Lord Hylton	Genus / LSE:GNS.L	£2,678.00	£2,150.00	-19.72%	£56,198.66
Jan '24	Lord Kakkar	Cyte / NMS:CTKB	£8.31	£3.71	-55.35%	£31,251.50**
Apr '10	Lord Lloyd-Webber	Idexx Labs / NMS:IDXX	£29.96	£517.75	1,628.14%	£1,209,696.30
Aug '16	Lord Lloyd-Webber	Eli Lilly / NYQ:LLY	£80.55	£67.15	-16.64%	£58,355.06**
Apr '24	Lord Mendoza	Eli Lilly / NYQ:LLY	£731.33	£1,149.85	57.23%	£110,059.07
Apr '26	Lord Grabiner	Eli Lilly / NYQ:LLY	£955.19	£1,149.85	20.38%	£84,265.43
Mar '17	Lord Lloyd-Webber	Hikma Pharmaceuticals / LSE:HIK.L	£2,026.00	£1,571.00	-22.46%	£54,279.37
Sep '21	Lord Londesborough	Definitive Healthcare / NMS:DH	£43.29	£0.94	-97.84%	£1,513.51
Jul '21	Lord Londesborough	Goodrx / NMS:GDRX	£32.52	£4.79	-85.27%	£10,310.58**
Nov '23	Lord Mance	Eli Lilly Co / VIE:LLYC.VI	£557.00	£1,023.20	83.70%	£128,588.87
Mar '24	Lord Moynihan of Chelsea	Candel Therapeutics / NGM:CADL	£1.40	£10.16	625.71%	£507,999.99
Mar '24	Lord Moynihan of Chelsea	Journey Medical / NCM:DERM	£3.74	£7.25	93.85%	£135,695.19**
Mar '24	Lord Moynihan of Chelsea	Evotec / NMS:EVO	£7.13	£3.41	-52.17%	£33,478.26**
Mar '24	Lord Moynihan of Chelsea	Fortress Biotech / NCM:FBIO	£1.92	£2.07	7.81%	£75,468.75
Mar '24	Lord Moynihan of Chelsea	Mustang Bio / NCM:MBIO	£1.04	£0.47	-55.10%	£31,432.69
Mar '24	Lord Moynihan of Chelsea	Tg Therapeutics / NCM:TGTX	£15.05	£53.62	256.28%	£249,395.34
Mar '24	Lord Moynihan of Chelsea	Adaptimmune / NMS:ADAP	£1.47	£0.03	-98.28%	£1,207.14**
Mar '24	Lord Moynihan of Chelsea	Avenue Therapeutics / NCM:ATXI	£12.00	£0.36	-97.00%	£2,100.00
Apr '19	Lord Nash	Eq / NCM:EQ	£8.20	£0.69	-91.59%	£5,890.24**
Aug '23	Lord Nash	Relay / NGM:RLAY	£10.62	£18.49	74.11%	£121,873.82
Sep '23	Lord Nash	Abingdon / LSE:ABDX.L	£11.25	£11.00	-2.22%	£68,444.44
Mar '24	Lord Petitgas	Royalty Pharma / NMS:RPRX	£30.08	£57.63	91.59%	£134,112.37
Mar '24	Lord Petitgas	Moderna / NMS:MRNA	£111.98	£188.94	68.73%	£118,108.59
May '23	Lord Reay	Sanofi / NMS:SNY	£55.11	£47.22	-14.32%	£59,978.23**
May '22	Lord Saatchi	Walgreen / NMS:WBA	£43.85	£11.98	-72.68%	£19,124.29
Jul '23	Lord Sassoon	Haleon / LSE:HLN.L	£336.10	£327.80	-2.47%	£68,271.34
Mar '23	Baroness Shields	Benevolentai / AMS:BAI.AS	£2.46	£0.09	-96.14%	£2,703.25**
Jan '21	Lord Spencer of Alresford	Immupharma / LSE:IMM.L	£12.65	£3.49	-72.37%	£19,339.92
May '23	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£180.80	£204.10	12.89%	£79,023.12**
Jun '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£208.20	£197.20	-5.28%	£66,301.63**
Aug '24	Lord Sterling of Plaistow	Essilorluxottica / PAR:EL.PA	£207.50	£144.60	-30.31%	£48,780.72
Mar '25	Lord Fink	Essilorluxottica / PAR:EL.PA	£273.20	£144.60	-47.07%	£37,049.78
Jun '22	Lord Stevens of Ludgate	Verici Dx / LSE:VRCI.L	£26.00	£0.22	-99.13%	£605.77
May '23	Lord Stevens of Ludgate	Avacta Group / LSE:AVCT.L	£112.00	£72.00	-35.71%	£45,000.00
Jul '25	Lord Fink	Avacta Group / LSE:AVCT.L	£51.50	£72.00	39.81%	£97,864.08
Jun '22	Lord Sugar	Acl / NMS:ACLX	£17.47	£115.07	558.67%	£461,070.43
May '22	Lord Triesman	Blue / NMS:BLUE	£3.39	£4.97	46.61%	£102,625.36
May '20	Lord Wolfson of Aspley Guise	Adc Therapeutics / NYQ:ADCT	£30.00	£1.08	-96.40%	£2,520.00
Nov '24	Lord Moynihan of Chelsea	Sab Biotherapeutics / NCM:SABS	£3.95	£3.06	-22.53%	£54,227.85

* Minimum Potential Value based on £70,000.00 invested at time of declaration.

** Interest ceased/exited on filed date.